Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2007-4-30
pubmed:abstractText
The pollen of Brassica napus L. has been used in China to treat benign prostatic hyperplasia (BPH) for over decades. In this study, the pollen of Brassica napus L. was extracted successively with chloroform, ethyl acetate and ethanol. The ethyl acetate extract showed strong activity in decreasing the secretion of prostate specific antigen (PSA) in LNCaP cells as compared to two other extracts, measured by ELISA with finasteride as positive control in the assay. Five flavonoids were subsequently isolated from the active extract using bioassay-guided fractionation. They were Naringenin (1); Luteolin (2); Kaempferol (3); Kaempferol 3-(3-E-p-coumaroyl-alpha-L-rhamnopyranoside) (4); and Kaempferol 3-(2,3-di-E-p-coumaroyl-alpha-L-rhamnopyranoside) (5). All these compounds inhibited PSA secretion significantly, with IC50 values in the range of 5-50 microM. Compounds 2, 4 and 5 showed moderate cytotoxicity to LNCaP cells within the active concentration range, while compounds 1 and 3 showed no cytotoxicity. Further studies on the mechanism action of these compounds were performed by evaluating their activation of estrogen receptor (ER) and antagonistic activities on androgen receptor (AR) in cell-based reporter gene assays. All compounds described here were first isolated from the pollen of Brassica napus L.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0944-7113
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
338-43
pubmed:meshHeading
pubmed-meshheading:17085029-Brassica napus, pubmed-meshheading:17085029-Cell Line, Tumor, pubmed-meshheading:17085029-DNA Primers, pubmed-meshheading:17085029-Down-Regulation, pubmed-meshheading:17085029-Flavonoids, pubmed-meshheading:17085029-Gene Expression Regulation, Neoplastic, pubmed-meshheading:17085029-Humans, pubmed-meshheading:17085029-Inhibitory Concentration 50, pubmed-meshheading:17085029-Male, pubmed-meshheading:17085029-Phytotherapy, pubmed-meshheading:17085029-Plant Extracts, pubmed-meshheading:17085029-Pollen, pubmed-meshheading:17085029-Prostate-Specific Antigen, pubmed-meshheading:17085029-Prostatic Hyperplasia, pubmed-meshheading:17085029-RNA, pubmed-meshheading:17085029-Receptors, Androgen, pubmed-meshheading:17085029-Receptors, Estrogen, pubmed-meshheading:17085029-Reverse Transcriptase Polymerase Chain Reaction
pubmed:year
2007
pubmed:articleTitle
Down-regulation of prostate specific antigen in LNCaP cells by flavonoids from the pollen of Brassica napus L.
pubmed:affiliation
College of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110015, PR China.
pubmed:publicationType
Journal Article